Company / Net Income
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$546.4M
FY2025
5-year range
-$546.4M / -$181.2M
FY2021-FY2025
Trend
-76.3%
vs FY2024
Sector context
#157 of 164
Health Care
What the data says
Among 164 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 4% for net income. Net Income has fluctuated over the past 10 years, ranging from -$546M in FY2025 to $29M in FY2020.
Based on SEC 10-K filings.
-$546M in FY2025.
Declined from -$307M to -$546M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 164This company -$546.4M Sector average $467.5M
▼
-216.9% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 76.3% year-over-year.
- Ranks #157 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$546.4M | -76.3% |
| FY2024 | -$309.9M | -1.0% |
| FY2023 | -$306.7M | +2.4% |
| FY2022 | -$314.2M | -73.4% |
| FY2021 | -$181.2M | -716.3% |
| FY2020 | $29.4M | +134.9% |
| FY2019 | -$84.1M | +18.0% |
| FY2018 | -$102.6M | -11.3% |
| FY2017 | -$92.2M | -24.0% |
| FY2016 | -$74.4M | +6.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026